My Cart
Search
Advanced Search
Popular Searches
hla (376)
HLA–B (132)
Hla C 06 (376)
hla test (376)
Recent Searches
hla (376)
apple app site association (8)
v2 (376)
v1 (376)
Menu
Back to Home
  • News & Events

News & Events

Stay up to date with the latest product launches, promotions, and technical resources direct to your inbox.

FEATURED APPLICATION

The Search for Vaccine Targets For COVID-19

The University of Oklahoma Health Sciences Center has launched a research collaboration with Pure MHC, LLC an innovative biotechnology company, to work toward the development of a vaccine for the COVID-19 virus.

"With OU, we are acquiring the actual COVID-19 virus, and we will infect cells and look for the targets on the infected cells. We will use those targets to either develop a vaccine or to directly target them with something like monoclonal antibodies."

Curtis McMurtrey, PhD,

Director of Immuno-Proteomics for Pure MHC and a graduate of the OU Health Sciences Center.

LEARN MORE
Chris McMurtrey, director of immuno-proteomics for Pure MHC

News from Pure Protein

NEWS
Pure Transplant Solutions Announces Collaboration with King’s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

OKLAHOMA CITY, OK, AUSTIN, TX,  AND LONDON, ENGLAND – Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King’s College London, a leading university […]

 February 24, 2021
Pure Protein, LLC and Pure Transplant Solutions, LLC Promote Blake Harlan to President and Dr. Rico Buchli to Vice President of Products and Services

AUSTIN, Texas and OKLAHOMA CITY, Okla., Feb. 4, 2021 – Pure Protein, LLC (Pure Protein) and subsidiary company Pure Transplant Solutions, LLC (PTS), announced today that Blake Harlan has been promoted to President and Rico Buchli, PhD to Vice President of Products and Services.    

 February 04, 2021
Pure Transplant Solutions, LLC and University Hospital Basel Announce Research Collaboration Developing New Diagnostics for Donor Specific Antibodies (DSA) in Transplant Rejection

Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with the Transplantation Immunology & Nephrology Department of the University Hospital of Basel, to develop new […]

 January 27, 2021